Sun Pharmaceutical Industries Limited has informed the Exchange that Board of Directors at its meeting held on January 31, 2026, declared Interim Dividend of 11 per equity share.
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Sun Pharmaceutical Industries Limited, at a meeting held on January 31, 2026, declared an interim dividend of ₹11 per equity share. The company, one of India's largest pharmaceutical firms, regularly rewards shareholders through dividends. The record date and payment timeline will be communicated separately by the company. Interim dividends are paid out of company profits during the financial year, before the final dividend is declared.
Shareholders holding shares as of the record date will be eligible to receive this dividend. The declaration signals continued profitability and shareholder returns, which is generally viewed positively by the market.